Related Experiment Video

Updated: Aug 11, 2026

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

[Tumor multidrug-resistance and reversing actions of traditional Chinese medicine]

Jun-dong Feng1, Xiao-yu Xu

  • 1College of Traditional Chinese Medicine, Chongqing Medical University, Chongqing, 400050, China. fengjun-dong2001@sohu.com

Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica
|December 4, 2004
PubMed

Insights

Multidrug-resistance (MDR) in tumors hinders chemotherapy. This review explores MDR mechanisms and traditional Chinese medicine

Area of Science:

  • Oncology
  • Pharmacology
  • Biochemistry

Background:

  • Tumor multidrug-resistance (MDR) significantly limits the efficacy of chemotherapy.
  • Understanding MDR mechanisms is crucial for developing effective anti-cancer therapies.
  • Traditional Chinese medicine (TCM) has shown potential in overcoming MDR.

Purpose of the Study:

  • To review recent advances in understanding the mechanisms of tumor multidrug-resistance.
  • To summarize current research on traditional Chinese medicine's role in reversing MDR.
  • To discuss the mechanisms and key features of TCM in overcoming MDR.

Main Methods:

  • Literature review of scientific publications on MDR mechanisms.
  • Analysis of studies investigating traditional Chinese medicine for MDR reversal.
  • Synthesis of information on the molecular and cellular basis of MDR and TCM interventions.

Main Results:

  • MDR involves complex mechanisms including P-glycoprotein, MRP1, apoptosis evasion, and DNA repair.
  • Several traditional Chinese medicines exhibit MDR-reversing properties.
  • TCM interventions target various pathways involved in MDR development and progression.

Conclusions:

  • Advances in MDR research highlight its multifaceted nature.
  • Traditional Chinese medicine offers promising strategies for overcoming chemotherapy resistance.
  • Further research into TCM mechanisms can lead to novel anti-MDR therapies.

More Related Videos

Establishment of Coloproctitis Cancer Model in Mice and Evaluation of Therapeutic Effect of Chinese Medicine06:24

Establishment of Coloproctitis Cancer Model in Mice and Evaluation of Therapeutic Effect of Chinese Medicine

Published on: October 13, 2023

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...